Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Kriegsmann, K.; Hundemer, M.; Hofmeister-Mielke, N.; Reichert, P.; Manta, C.-P.; Awwad, M.H.S.; Sauer, S.; Bertsch, U.; Besemer, B.; Fenk, R.; Hänel, M.; Munder, M.; Weisel, K.C.; Blau, I.W.; Neubauer, A.; Müller-Tidow, C.; Raab, M.S.; Goldschmidt, H.; Huhn, S.; for the German-speaking Myeloma Multicenter Group. Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment. Cancers 2020, 12, 2322. https://doi.org/10.3390/cancers12082322
Kriegsmann K, Hundemer M, Hofmeister-Mielke N, Reichert P, Manta C-P, Awwad MHS, Sauer S, Bertsch U, Besemer B, Fenk R, Hänel M, Munder M, Weisel KC, Blau IW, Neubauer A, Müller-Tidow C, Raab MS, Goldschmidt H, Huhn S, for the German-speaking Myeloma Multicenter Group. Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment. Cancers. 2020; 12(8):2322. https://doi.org/10.3390/cancers12082322
Chicago/Turabian StyleKriegsmann, Katharina, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Manta, Mohamed H.S. Awwad, Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja C. Weisel, Igor W. Blau, Andreas Neubauer, Carsten Müller-Tidow, Marc S. Raab, Hartmut Goldschmidt, Stefanie Huhn, and for the German-speaking Myeloma Multicenter Group. 2020. "Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment" Cancers 12, no. 8: 2322. https://doi.org/10.3390/cancers12082322